Those who have suffered a pharmaceutical injury have legal protections available to assist them when harmed by a defective drug. Drug companies Johnson & Johnson and Bayer are facing such legal action concerning blood thinner, Xarelto. Those who filed the claims assert that they suffered severe internal bleeding, which required hospital attention, after taking the drug. The uncontrolled bleeding can be fatal and, unlike other longstanding blood-thinning drugs, Xarelto does not have an antidote. A woman who suffered severe gastrointestinal bleeding after taking Xarelto in 2013, which required a hospital stay, is amongst those who have brought a claim against the pharmaceutical companies.
The victim asserts that the drug companies continued to sell the drug even though they were aware of its risks and that the drug companies failed to warn the public of the dangers of taking the drug. Under pharmaceutical liability laws, drug manufacturers have a duty to warn the public of side effects that are known to occur when using the drug in question. Drug manufacturers also have a continuing duty to warn and update warnings concerning any adverse side effects.
Those who have suffered a pharmaceutical injury may wish to bring a pharmaceutical liability lawsuit. Drug liability may at times seem complex, and a successful pharmaceutical liability lawsuit may require expert testimony and other more specialized types of evidence, however, because of the impact of harmful drugs, which can include serious injury and death, an experienced attorney can help simplify the process for victims. If successful, a claim may help a victim recover damages, including medical expenses, lost wages, and pain and suffering.
Pharmaceutical liability lawsuits serve the dual purpose of keeping the public safe and reimbursing victims. Therefore, those who have been injured by a defective drug should consider aggressively acting on their legal rights, not only protect themselves but to send the industry a message that safety is the top priority, and failing to keep consumers safe will result in harsh financial punishment.
